Laboratory Corporation of America Holdings
Equities
LH
US50540R4092
Healthcare Facilities & Services
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
204.2 USD | +2.91% | +0.54% | -10.17% |
Apr. 29 | Labcorp Receives US FDA's Approval for Companion Diagnostic Device for Use With Pfizer's Hemophilia B Gene Therapy | MT |
Apr. 29 | US FDA publishes final rule for laboratory developed tests | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.17% | 17.21B | |
-14.58% | 85.02B | |
+15.05% | 82.37B | |
+10.49% | 29.29B | |
-0.29% | 16.7B | |
-31.05% | 11.8B | |
+2.53% | 12.15B | |
+31.86% | 12.12B | |
-2.27% | 12.13B | |
-8.00% | 11.67B |
- Stock Market
- Equities
- LH Stock
- News Laboratory Corporation of America Holdings
- BofA Securities Adjusts Price Target on Laboratory Corp of America to $230 From $238, Maintains Buy Rating